NCT02084251View on ClinicalTrials.gov

Clinical Trial for PB-119 in Healthy Subjects (Phase I)

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Type II Diabetes
Interventions
DRUG

PB-119

Trial Locations (1)

100000

Peking University First Hospital, Beijing

All Listed Sponsors
lead

PegBio Co., Ltd.

OTHER

NCT02084251 - Clinical Trial for PB-119 in Healthy Subjects (Phase I) | Biotech Hunter | Biotech Hunter